SCHEMBL9532272

SCHEMBL9532272

CCCC(=O)N1CCN([C]=O)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
ALDH1A1 P00352 3/20 0.43
CYP3A4 P08684 2/20 0.43
USP2 O75604 2/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GNAI3 P08754 2/20 0.43
GNAI1 P63096 2/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
CHRNB3 Q05901 1/20 0.43
CHRNA6 Q15825 1/20 0.43
MAPT P10636 4/20 0.42
POLB P06746 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9534894 0.89 CHRNB2 (0.41) L3MBTL1MEN1KMT2ATDP1ALDH1A1
SCHEMBL7036074 0.85 GNAI3 (0.63) L3MBTL1MEN1KMT2ATDP1GNAI3
SCHEMBL674671 0.85
SCHEMBL10663507 0.85 L3MBTL1 (0.58) L3MBTL1MEN1KMT2ATDP1ALDH1A1
SCHEMBL8984773 0.83 BLM (0.46) MEN1KMT2ATDP1ALDH1A1CYP3A4
SCHEMBL9536777 0.78 L3MBTL1 (0.49) L3MBTL1MEN1KMT2ATDP1GNAI3
SCHEMBL805507 0.77 GNAI3 (0.50) L3MBTL1MEN1KMT2ATDP1ALDH1A1
SCHEMBL12457130 0.77 TDP1 (0.50) L3MBTL1MEN1KMT2ATDP1ALDH1A1
SCHEMBL805464 0.76 L3MBTL1 (0.72) L3MBTL1MEN1KMT2ATDP1ALDH1A1
SCHEMBL9762642 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0277836-B1 THIAZOLIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR USE Sankyo Company Limited (JP) 1993-06-02 EP disclosed
US-5104888-A Anticholesterol or antidiabetic agents SANKYO COMPANY, LIMITED (JP) 1992-04-14 US disclosed
EP-0207581-B1 THIAZOLIDINE DERIVATIVES, THEIR PREPARATION AND USE SANKYO COMPANY LIMITED (JP) 1990-09-12 EP disclosed
US-4873255-A REDUCE BLOOD GLUCOSE AND BLOOD LIPID LEVELS SANKYO COMPANY LIMITED (JP) 1989-10-10 US disclosed
EP-0277836-A1 Thiazolidinone derivatives, their preparation and their use Sankyo Company Limited (JP) 1988-08-10 EP disclosed
EP-0207581-A2 Thiazolidine derivatives, their preparation and use SANKYO COMPANY LIMITED (JP) 1987-01-07 EP disclosed